Nutra Pharma Corp. financial statements
Nutra Pharma Corp.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 257.61K | 10-K |
| Net income | −USD 2.05M | 10-K |
| Cash and equivalents | USD 12.18K | 10-K |
| Total debt | USD 9.76M | 10-Q |
Nutra Pharma Corp. financials on 6ix · Nutra Pharma Corp. on 6ix